These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1341322)
1. The quandary of experimental chemotherapy. Modan B Med Oncol Tumor Pharmacother; 1992; 9(3):111-2. PubMed ID: 1341322 [No Abstract] [Full Text] [Related]
2. [Recent proposals for early stage clinical trials of cancer]. Ohashi Y Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():292-4. PubMed ID: 7986106 [TBL] [Abstract][Full Text] [Related]
3. [Current status and issues in clinical trials of anticancer agents]. Kojima H Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107 [TBL] [Abstract][Full Text] [Related]
4. Adaptive design may hasten clinical trials. Schmidt C J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993 [No Abstract] [Full Text] [Related]
5. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan]. Andoh M; Fujiwara Y; Shimada Y Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363 [TBL] [Abstract][Full Text] [Related]
6. The impact of regulations, tradition, and experimental design on clinical cancer trials: report and recommendations resulting from Washington Cancer Trials Conference. Lasagna L; Frei E Am J Clin Oncol; 1996 Aug; 19(4):325-9. PubMed ID: 8677898 [No Abstract] [Full Text] [Related]
14. New drug development for pediatric oncology. Weitman S; Carlson L; Pratt CB Invest New Drugs; 1996; 14(1):1-10. PubMed ID: 8880388 [No Abstract] [Full Text] [Related]
15. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle theories slowly turn into practice. Bender E Cancer Discov; 2011 Sep; 1(4):280. PubMed ID: 22586600 [No Abstract] [Full Text] [Related]
17. Should terminally ill patients have the right to take drugs that pass phase I testing? No. Gesme D BMJ; 2007 Sep; 335(7618):479. PubMed ID: 17823188 [TBL] [Abstract][Full Text] [Related]
18. The importance of phase I/II trials in pediatric oncology. MacArthur CA; Vietti T Invest New Drugs; 1996; 14(1):33-5. PubMed ID: 8880391 [TBL] [Abstract][Full Text] [Related]
19. Regional chemotherapy: revisited. Markman M J Cancer Res Clin Oncol; 1996; 122(1):1-2. PubMed ID: 8543586 [No Abstract] [Full Text] [Related]